AspenBio Pharma, Inc. - Financial and Strategic Analysis Review

AspenBio Pharma, Inc. - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “AspenBio Pharma, Inc. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of AspenBio Pharma, Inc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

AspenBio Pharma, Inc. (AspenBio) is an emerging biotechnology company that is principally engaged in the discovery, development, manufacture, licensing and marketing of novel drugs and diagnostics for humans and animals. The company's key customers include the medical institutions and hospitals. Its product line includes Antibody Products, Human Hormone Products and Tumor Market Products. The company continues to develop and test its two first-generation blood-based human diagnostic tests to diagnose or rule out appendicitis in patients suffering from abdominal pain. The company is headquartered in Castle Rock, Colorado, the US.

Recent Developments

Aug 21, 2009: FDA Requests Additional Information For AppyScore Test
Aug 21, 2009: FDA Requests AspenBio Pharma For Additional Information Regarding 510(k) Filing For AppyScore
Sep 16, 2009: AspenBio Appoints Greg Bennett As Vice President Of Product Development And Manufacturing

Scope

• Provides key company information for business intelligence needs
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the company.
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the market opportunities available to them.
• Compare your company’s financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.